In vivo studies, LOX‐1 expression is increased in experimental and clinical studies of hypertension, hyperlipidemia, type 2 diabetes mellitus, obesity, and carotid artery atherosclerosis.25, 26, 27, 28, 29. Here, OLR1 is linked to hyperlipidemia.